APA (7th ed.) Citation

Yamashita, M., Matsumoto, M., Hayakawa, M., Sakai, K., Fujimura, Y., & Ogata, N. (2018). Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration. Nature Portfolio.

Chicago Style (17th ed.) Citation

Yamashita, Mariko, Masanori Matsumoto, Masaki Hayakawa, Kazuya Sakai, Yoshihiro Fujimura, and Nahoko Ogata. Intravitreal Injection of Aflibercept, an Anti-VEGF Antagonist, Down-regulates Plasma Von Willebrand Factor in Patients with Age-related Macular Degeneration. Nature Portfolio, 2018.

MLA (8th ed.) Citation

Yamashita, Mariko, et al. Intravitreal Injection of Aflibercept, an Anti-VEGF Antagonist, Down-regulates Plasma Von Willebrand Factor in Patients with Age-related Macular Degeneration. Nature Portfolio, 2018.